MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,723,908 | +21.7% | 544,626 | +1.0% | 0.02% | +26.3% |
| Q2 2023 | $19,490,329 | +0.2% | 539,450 | +3.1% | 0.02% | -5.0% |
| Q1 2023 | $19,458,785 | -17.6% | 523,367 | +0.4% | 0.02% | -20.0% |
| Q4 2022 | $23,610,315 | -23.6% | 521,084 | +17.8% | 0.02% | -26.5% |
| Q3 2022 | $30,895,000 | +4.0% | 442,373 | -0.1% | 0.03% | +9.7% |
| Q2 2022 | $29,719,000 | -18.1% | 442,710 | +0.3% | 0.03% | 0.0% |
| Q1 2022 | $36,308,000 | -35.6% | 441,587 | +14.9% | 0.03% | +3.3% |
| Q4 2021 | $56,360,000 | -19.7% | 384,202 | -3.1% | 0.03% | -23.1% |
| Q3 2021 | $70,167,000 | +9.7% | 396,627 | +0.2% | 0.04% | +14.7% |
| Q2 2021 | $63,943,000 | +9.1% | 395,860 | +15.7% | 0.03% | +13.3% |
| Q1 2021 | $58,626,000 | +75.9% | 342,246 | +125.5% | 0.03% | +87.5% |
| Q4 2020 | $33,333,000 | +5.0% | 151,763 | -20.6% | 0.02% | -15.8% |
| Q3 2020 | $31,758,000 | +33.0% | 191,252 | -8.6% | 0.02% | +11.8% |
| Q2 2020 | $23,885,000 | +106.7% | 209,211 | +39.1% | 0.02% | +70.0% |
| Q1 2020 | $11,558,000 | -33.5% | 150,365 | +11.4% | 0.01% | -23.1% |
| Q4 2019 | $17,388,000 | +6.8% | 134,941 | -35.4% | 0.01% | -7.1% |
| Q3 2019 | $16,283,000 | -33.1% | 208,989 | -11.6% | 0.01% | -36.4% |
| Q2 2019 | $24,355,000 | +17.3% | 236,460 | -16.5% | 0.02% | +15.8% |
| Q1 2019 | $20,761,000 | +6.6% | 283,240 | -38.3% | 0.02% | -5.0% |
| Q4 2018 | $19,484,000 | -8.0% | 459,303 | +2.2% | 0.02% | +5.3% |
| Q3 2018 | $21,167,000 | +1602.9% | 449,408 | +1682.9% | 0.02% | +1800.0% |
| Q2 2018 | $1,243,000 | +237.8% | 25,206 | +110.2% | 0.00% | – |
| Q1 2018 | $368,000 | +128.6% | 11,992 | -72.9% | 0.00% | – |
| Q2 2017 | $161,000 | +42.5% | 44,217 | +87.1% | 0.00% | – |
| Q4 2016 | $113,000 | -22.1% | 23,639 | +7.2% | 0.00% | – |
| Q3 2016 | $145,000 | -35.0% | 22,058 | -45.9% | 0.00% | – |
| Q2 2016 | $223,000 | -28.5% | 40,787 | +179.4% | 0.00% | – |
| Q1 2016 | $312,000 | -60.4% | 14,596 | -41.4% | 0.00% | -100.0% |
| Q4 2015 | $787,000 | -25.1% | 24,913 | -18.4% | 0.00% | 0.0% |
| Q3 2015 | $1,051,000 | +323.8% | 30,538 | +134.9% | 0.00% | – |
| Q1 2014 | $248,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |